Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00117273 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens
A Phase 3 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 36
- Enrollment target
NCT00117273 is a Phase 3 study that has completed, run by Duramed Research. The registered enrollment target is 36 participants.
The verdict
NCT00117273, a Phase 3 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a randomized, open-label study to evaluate pituitary ovarian suppression in healthy, reproductive-aged women using three different regimens of oral contraceptives (OCs). Two extended regimen OCs, Seasonale (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of placebo), and Seasonique (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of ethinyl estradiol 0.01 mg), and a 28-day regimen OC, Portia (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 21 days followed by 7 days of placebo).
Interventions
- DRUG Seasonale [levonorgestrel (LNG)/ethinyl estradiol (EE)]
- DRUG Seasonique (LNG/EE and EE)
- DRUG Portia (LNG/EE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00117273
The ClinicalTrials.gov registry entry for NCT00117273 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duramed Research, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Seasonale [levonorgestrel (LNG)/ethinyl estradiol (EE)] is the first listed.
NCT00117273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00117273 about?
NCT00117273 is a clinical study titled "A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens". This is a randomized, open-label study to evaluate pituitary ovarian suppression in healthy, reproductive-aged women using three different regimens of oral contraceptives (OCs). Two extended regimen OCs, Seasonale (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of place...
What is the current status of trial NCT00117273?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 36 participants. The study started on 2005-06. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00117273?
The interventions under investigation include: Seasonale [levonorgestrel (LNG)/ethinyl estradiol (EE)] (DRUG), Seasonique (LNG/EE and EE) (DRUG), Portia (LNG/EE) (DRUG).
Who is sponsoring clinical trial NCT00117273?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.